145 related articles for article (PubMed ID: 3625713)
1. Structural modification study of mitoxantrone (DHAQ). Chloro-substituted mono- and bis[(aminoalkyl)amino]anthraquinones.
Zee-Cheng RK; Mathew AE; Xu PL; Northcutt RV; Cheng CC
J Med Chem; 1987 Sep; 30(9):1682-6. PubMed ID: 3625713
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.
Zee-Cheng RK; Cheng CC
J Pharm Sci; 1982 Jun; 71(6):708-9. PubMed ID: 7097541
[TBL] [Abstract][Full Text] [Related]
3. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC
J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801
[TBL] [Abstract][Full Text] [Related]
4. N-(Aminoalkyl)imide antineoplastic agents. Synthesis and biological activity.
Zee-Cheng RK; Cheng CC
J Med Chem; 1985 Sep; 28(9):1216-22. PubMed ID: 4032424
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.
Zee-Cheng RK; Cheng CC
J Med Chem; 1978 Mar; 21(3):291-4. PubMed ID: 628005
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
7. 5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. Synthesis and biological evaluation.
Showalter HD; Johnson JL; Werbel LM; Leopold WR; Jackson RC; Elslager EF
J Med Chem; 1984 Mar; 27(3):253-5. PubMed ID: 6699870
[No Abstract] [Full Text] [Related]
8. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor evaluations of symmetrically and unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones.
Krapcho AP; Getahun Z; Avery KL; Vargas KJ; Hacker MP; Spinelli S; Pezzoni G; Manzotti C
J Med Chem; 1991 Aug; 34(8):2373-80. PubMed ID: 1875336
[TBL] [Abstract][Full Text] [Related]
10. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
11. 6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Stefańska B; Dzieduszycka M; Martelli S; Tarasiuk J; Bontemps-Gracz M; Borowski E
J Med Chem; 1993 Jan; 36(1):38-41. PubMed ID: 8421288
[TBL] [Abstract][Full Text] [Related]
12. Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses.
Wang BS; Murdock KC; Lumanglas AL; Damiani M; Silva J; Ruszala-Mallon VM; Durr FE
Int J Immunopharmacol; 1987; 9(6):733-9. PubMed ID: 2961707
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antineoplastic evaluation of 1,4-bis(aminoalkanamido)-9,10-anthracenediones.
Martelli S; Dzieduszycka M; Stefanska B; Bontemps-Gracz M; Borowski E
J Med Chem; 1988 Oct; 31(10):1956-9. PubMed ID: 3172129
[TBL] [Abstract][Full Text] [Related]
14. Antitumor properties of tetrahydrobenz[a]anthraquinone derivatives.
Morreal CE; Bernacki RJ; Hillman M; Atwood A; Cartonia D
J Med Chem; 1990 Feb; 33(2):490-2. PubMed ID: 2299618
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antitumor activity, and antiviral activity of 3-substituted 3-deazacytidines and 3-substituted 3-deazauridines.
McNamara DJ; Cook PD; Allen LB; Kehoe MJ; Holland CS; Teepe AG
J Med Chem; 1990 Jul; 33(7):2006-11. PubMed ID: 2163455
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of the antitumor activity of 2-substituted 1,4-dihydroxy-9,10-anthraquinones.
Tam MN; Nam NH; Jin GZ; Song GY; Ahn BZ
Arch Pharm (Weinheim); 2000 Jun; 333(6):189-94. PubMed ID: 10909191
[TBL] [Abstract][Full Text] [Related]
17. Experimental antitumor activity of aminoanthraquinones.
Johnson RK; Zee-Cheng RK; Lee WW; Acton EM; Henry DW; Cheng CC
Cancer Treat Rep; 1979 Mar; 63(3):425-39. PubMed ID: 427824
[TBL] [Abstract][Full Text] [Related]
18. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
[TBL] [Abstract][Full Text] [Related]
19. 2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
Capps DB; Dunbar J; Kesten SR; Shillis J; Werbel LM; Plowman J; Ward DL
J Med Chem; 1992 Dec; 35(26):4770-8. PubMed ID: 1479579
[TBL] [Abstract][Full Text] [Related]
20. Amino-substituted p-benzoquinones.
Mathew AE; Zee-Cheng RK; Cheng CC
J Med Chem; 1986 Sep; 29(9):1792-5. PubMed ID: 3746824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
